Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 33.21 USD 0.67% Market Closed
Market Cap: 16.9B USD
Have any thoughts about
Baxter International Inc?
Write Note

Baxter International Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Baxter International Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Baxter International Inc
NYSE:BAX
Pre-Tax Income
$166m
CAGR 3-Years
-51%
CAGR 5-Years
-36%
CAGR 10-Years
-16%
Becton Dickinson and Co
NYSE:BDX
Pre-Tax Income
$2B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Pre-Tax Income
$2.2B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
36%
Stryker Corp
NYSE:SYK
Pre-Tax Income
$4.2B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
Pre-Tax Income
$6.8B
CAGR 3-Years
-6%
CAGR 5-Years
12%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Pre-Tax Income
$2.4B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
15%
No Stocks Found

Baxter International Inc
Glance View

Market Cap
16.9B USD
Industry
Health Care

Baxter International Inc. is a global healthcare company that has been a trusted name in the medical sector for over eight decades. Founded in 1931, Baxter specializes in lifesaving medical products and therapies, primarily focusing on renal and hospital care. The company's innovations have revolutionized treatment protocols for conditions such as kidney failure, where their dialysis products are vital for patient care. Additionally, Baxter manufactures a diverse range of infusion systems, biosurgery products, and medications, playing a crucial role in surgical and medical environments. With a commitment to improving patient outcomes, Baxter invests heavily in research and development, which positions it well for future growth, particularly as global healthcare needs continue to expand. As an investor, understanding Baxter’s strategic position in the healthcare industry is key. The company enjoys a robust financial footing, bolstered by its extensive product portfolio and a global distribution network that spans over 100 countries. Recently, Baxter has focused on enhancing its operational efficiency and pursuing strategic acquisitions to broaden its product offerings and enter emerging markets. Moreover, as healthcare systems worldwide prioritize chronic disease management, Baxter’s innovative solutions are increasingly in demand, reinforcing its potential for sustainable revenue growth. In an ever-evolving healthcare landscape, Baxter International Inc. stands out as a formidable player, driven by a mission to save and sustain lives, making it an attractive option for long-term investors looking to enter the healthcare sector.

BAX Intrinsic Value
65.62 USD
Undervaluation 49%
Intrinsic Value
Price

See Also

What is Baxter International Inc's Pre-Tax Income?
Pre-Tax Income
166m USD

Based on the financial report for Sep 30, 2024, Baxter International Inc's Pre-Tax Income amounts to 166m USD.

What is Baxter International Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-16%

The average annual Pre-Tax Income growth rates for Baxter International Inc have been -51% over the past three years , -36% over the past five years , and -16% over the past ten years .

Back to Top